Drug metabolism in drug discovery and development

被引:216
作者
Zhang, Zhoupeng [1 ]
Tang, Wei [2 ]
机构
[1] Merck Sharp & Dohme Corp, Dept Pharmacokinet Pharmacodynam & Drug Metab, West Point, PA 19486 USA
[2] Shanghai ChemPartners, Shanghai 201203, Peoples R China
关键词
Bioactivation; Drug discovery and development; Drug metabolism; Metabolite; Pharmacokinetics; Pharmacodynamics; Safety; Toxicity; IN-VITRO BIOACTIVATION; LIVER-MICROSOMES; N-DEMETHYLATION; IDENTIFICATION; CYTOCHROME-P450; LIPOPHILICITY; ADDUCTS; PHARMACOKINETICS; AMITRIPTYLINE; PERSPECTIVE;
D O I
10.1016/j.apsb.2018.04.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered. This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure-activity relationships (SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism, drug-drug interactions (DDI) and formation of reactive metabolites. (C) 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 48 条
  • [11] Tenofovir disoproxil fumarate
    Gallant, JE
    Deresinski, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (07) : 944 - 950
  • [12] Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites
    Gan, JP
    Harper, TW
    Hsueh, MM
    Qu, QL
    Humphreys, WG
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (05) : 896 - 903
  • [13] GOTOH O, 1992, J BIOL CHEM, V267, P83
  • [14] HARADA N, 1984, J BIOL CHEM, V259, P3005
  • [15] A Trapping Method for Semi-quantitative Assessment of Reactive Metabolite Formation Using [35S]Cysteine and [14C]Cyanide
    Inoue, Kazuko
    Shibata, Yoshihiro
    Takahashi, Hiroyuki
    Ohe, Tomoyuki
    Chiba, Masato
    Ishii, Yasuyuki
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (03) : 245 - 254
  • [16] Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors
    Le, MT
    Vanderheyden, PML
    Szaszák, M
    Hunyady, L
    Kersemans, V
    Vauquelin, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (08) : 1329 - 1338
  • [17] Compound lipophilicity for substrate binding to human P450s in drug metabolism
    Lewis, DFV
    Jacobs, MN
    Dickins, M
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (12) : 530 - 537
  • [18] Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism
    Lewis, DFV
    Dickins, M
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 (01) : 1 - 18
  • [19] Drug Metabolism and Pharmacokinetics of 4-Substituted Methoxybenzoyl-aryl-thiazoles
    Li, Chien-Ming
    Lu, Yan
    Narayanan, Ramesh
    Miller, Duane D.
    Dalton, James T.
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 2032 - 2039
  • [20] In Vitro Bioactivation of a Selective Estrogen Receptor Modulator (2S,3R)-(+)-3-(3-Hydroxyphenyl)-2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol (I) in Liver Microsomes: Formation of Adenine Adducts
    Li, Ying
    Doss, George A.
    Li, Yan
    Chen, Qing
    Tang, Wei
    Zhang, Zhoupeng
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (11) : 2368 - 2377